2023 Overdose Epidemic Report

The American Medical Association Substance Use and Pain Care Task Force continues to advance evidence-based recommendations for policymakers and physicians to help end the nation’s drug-related overdose and death epidemic. Physicians’ positive actions, however, are limited by an insufficient focus on meaningful policy implementation and enforcement to support affordable, accessible, evidence-based care for patients with a substance use disorder, pain, or access to harm reduction services such as naloxone, syringe services programs and fentanyl test strips.

We urge all stakeholders to come together to help reverse this national epidemic.

Read more in the 2023 Overdose Epidemic Report.



AMA 2023 Overdose Report IQVIA Data Naloxone

Added 11/8/23

Be part of the solution.

Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.